News
They were randomised in a 2:1 ratio to receive either mifepristone (300–900 mg daily) or placebo for 24 weeks. Randomisation ...
New fluorescent drug lights up nerve tissue under special imaging equipment, giving surgeons a visual edge during procedure.
An open letter signed by more than 50 industry executives blasts a “fundamentally, fatally flawed” report that urges greater ...
FDA Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous.
In her new book, Access, Rebecca Grant chronicles activists' decades-long fight to defy abortion restrictions—including the ...
The number of abortions in the U.S. continued to climb in 2024, driven in part by a dramatic increase in telemedicine access, ...
U.S. Sen. James Lankford and 2nd District Congressman Josh Brecheen have asked the Environmental Protection Agency to assess the “environmental risks” of the abortion drug mifepristone. The ...
A pro-abortion rights activist holds a box of mifepristone during a rally in front of the US Supreme Court on March 26, 2024, in Washington, DC. | Drew Angerer/AFP via Getty Images A new report ...
A nurse drops Mifepristone, the first pill in a medical abortion, into a patient's hand at Alamo Women's Clinic in Carbondale, Ill., April 9, 2024.(Evelyn Hockstein/Reuters) ...
The attorneys general of New York, California, Massachusetts and New Jersey on Thursday asked the US Food and Drug Administration (FDA) to remove some of the restrictions on access to mifepristone, ...
Hosted on MSN29d
4 States Ask FDA to Lift Rules on Abortion Pill MifepristoneKey Takeaways Four states want federal regulators to ease restrictions on the abortion pill mifepristoneThey say the current rules make it harder for doctors to prescribe it safelyResearch shows ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results